Citric acid-modified pH-sensitive bone-targeted delivery of estrogen for the treatment of postmenopausal osteoporosis

Citric acid-modified pH-sensitive bone-targeted delivery of estrogen for the treatment of postmenopausal osteoporosis

Bone targeted delivery of estrogen offers great promise for the clinical application of estrogen in the treatment of postmenopausal osteoporosis (PMOP). However, the current bone-targeted drug delivery system still has several issues that need to be solved, such as the side effects of bone-targeted...

Full description

Bibliographic Details
Main Authors: Zhong-Hua Chen, De-Yan Du, Yi-Fei Fu, Jun-Jie Wu, Dan-Yang Guo, Yue-Yue Li, Meng-Nan Chen, Zheng-Dong Yuan, Kai-Wen Zhang, Zhen-Yu Zhang, Xia Li, Feng-Lai Yuan
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:Materials Today Bio
Subjects:
Postmenopausal osteoporosis
Citric acid
Bone-targeted
pH-sensitive
Side effects
Online Access:http://www.sciencedirect.com/science/article/pii/S2590006423002077

Similar Items

Similar Items